MM
Mark Massaro BTIG Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Lucid Diagnostics
LUCD
$140M
| $1.37 | $2.50 |
82%
upside
| Buy |
5 Sep ‘25
3 days ago |
|
2
Guardant Health
GH
$7.5B
| $60.13 | $70 |
16%
upside
| Buy |
4 Sep ‘25
3 days ago |
|
3
Ginkgo Bioworks
DNA
$660M
| $11.15 | $9 |
19%
downside
| Sell |
25 Aug ‘25
14 days ago |
|
|
TEM
4
Tempus AI, Inc. Class A Common Stock
TEM
$13.8B
| $79.62 | $85 |
7%
upside
| Buy |
20 Aug ‘25
19 days ago |
|
5
Exact Sciences
EXAS
$10.2B
| $53.81 | $60 |
12%
upside
| Buy |
12 Aug ‘25
27 days ago |
|
6
Adaptive Biotechnologies
ADPT
$1.96B
| $12.85 | $9 |
30%
downside
| Buy |
18 Dec ‘24
8 months ago |
|
7
Personalis
PSNL
$465M
| $5.24 | $7 |
34%
upside
| Buy |
16 Aug ‘24
1 year ago |
|
8
Zoetis
ZTS
$67.9B
| $153.32 | $225 |
47%
upside
| Buy |
12 Aug ‘24
1 year ago |
|
9
Natera
NTRA
$23.1B
| $168.02 | $135 |
20%
downside
| Buy |
9 Aug ‘24
1 year ago |
|
10
GeneDx Holdings
WGS
$3.81B
| $132.54 | $45 |
66%
downside
| Buy |
31 Jul ‘24
1 year ago |
|
11
Idexx Laboratories
IDXX
$51.4B
| $642.99 | $580 |
10%
downside
| Buy |
25 Jul ‘24
1 year ago |
|
12
NeoGenomics
NEO
$1.03B
| $7.98 | $21 |
163%
upside
| Buy |
2 May ‘24
1 year ago |
|
13
MDxHealth
MDXH
$175M
| $3.53 | $8 |
127%
upside
| Buy |
7 Mar ‘24
1 year ago |
|
14
SOPHiA GENETICS
SOPH
$219M
| $3.24 | $8 |
147%
upside
| Buy |
6 Mar ‘24
1 year ago |
|
15
Castle Biosciences
CSTL
$683M
| $23.56 | $30 |
27%
upside
| Buy |
15 Jun ‘23
2 years ago |
|
16
Exagen
XGN
$213M
| $9.67 | $5 |
48%
downside
| Buy |
22 Mar ‘23
2 years ago |
|
17
CareDx
CDNA
$736M
| $13.82 | $25 |
81%
upside
| Buy |
28 Feb ‘23
2 years ago |
|
|
IMDX
18
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71M
| $2.48 | $100 |
3,932%
upside
| Buy |
30 Nov ‘20
4 years ago |
|
19
Illumina
ILMN
$15.7B
| $98.93 | $300 |
203%
upside
| Hold |
22 Sep ‘20
5 years ago |
|
|
20
Natera
NTRA
$23.1B
| $168.02 | $65 |
61%
downside
| Buy |
6 Aug ‘20
5 years ago |
|